A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming.
about
Psychological and educational interventions for atopic eczema in childrenComplementary and alternative medicine treatments for atopic eczemaLoss of corneodesmosin leads to severe skin barrier defect, pruritus, and atopy: unraveling the peeling skin diseaseMutations in the filaggrin gene and food allergyEpidermal permeability barrier defects and barrier repair therapy in atopic dermatitisFilaggrin deficiency promotes the dissemination of cutaneously inoculated vaccinia virusFilaggrin failure - from ichthyosis vulgaris to atopic eczema and beyondFilaggrin in the frontline: role in skin barrier function and diseaseThe human epidermal differentiation complex: cornified envelope precursors, S100 proteins and the 'fused genes' familyTmem79/Matt is the matted mouse gene and is a predisposing gene for atopic dermatitis in human subjectsIncreased retinoic acid levels through ablation of Cyp26b1 determine the processes of embryonic skin barrier formation and peridermal developmentGene loss in keratinization programs accompanies adaptation of cetacean skin to aquatic lifestyleRe-appraisal of current theories for the development and loss of epidermal pigmentation in hominins and modern humansSkin barrier defects in atopic dermatitisFlow cytometry imaging identifies rare T(H)2 cells expressing thymic stromal lymphopoietin receptor in a "proallergic" milieu.Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptensEpidermal barrier defects link atopic dermatitis with altered skin cancer susceptibilityMast cells in atopic dermatitisThymic stromal lymphopoietin and the pathophysiology of atopic disease.Flaky tail mouse denotes human atopic dermatitis in the steady state and by topical application with Dermatophagoides pteronyssinus extract.Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigenEffectiveness and cost-effectiveness of daily all-over-body application of emollient during the first year of life for preventing atopic eczema in high-risk children (The BEEP trial): protocol for a randomised controlled trial.Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease.The infectious aspects of atopic dermatitis.Allergic asthma: influence of genetic and environmental factors.Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis preventionFilaggrin loss-of-function mutations are associated with food allergy in childhood and adolescencePeanut allergy: effect of environmental peanut exposure in children with filaggrin loss-of-function mutations.New insights into the epidemiology of childhood atopic dermatitis.The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma.The allergy gene: how a mutation in a skin protein revealed a link between eczema and asthma.Tight junction defects in patients with atopic dermatitis.Exacerbation of allergen-induced eczema in TLR4- and TRIF-deficient mice.Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis.Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy.Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy.Filaggrin genotype in ichthyosis vulgaris predicts abnormalities in epidermal structure and functionAtopic dermatitis: a disease of altered skin barrier and immune dysregulation.Genetic dissection of eosinophilic esophagitis provides insight into disease pathogenesis and treatment strategiesMatriptase deletion initiates a Sjögren's syndrome-like disease in mice.
P2860
Q24201204-A356ECA4-0DA9-4862-AB96-E4DEF74795D1Q24201373-D56554CE-1143-4AEA-BDC1-8E250CF26015Q24294533-E6304242-14B1-42B5-A486-0829AC3FF30DQ26999482-2594F84A-8550-475D-8F25-CC2A9CED1F1AQ27024192-4C0B0C98-56E1-43C7-BEAF-A24020B178AAQ27310377-0C551B31-A187-4D19-A879-E060913E3FC9Q28079701-8D24501C-A4FC-4730-BED1-FB459941743DQ28242202-C99F3360-108D-4C57-9E36-888165F718ACQ28264599-96F6E309-648D-4B05-8126-F65774DBE84FQ28511427-FDD67008-60B3-428D-B40F-A7084AFA9878Q28589751-5C95853E-4BCE-43C2-AE6B-44E28C18752BQ28645965-3CE67ABF-38E6-4520-B827-15787D84112CQ28703861-95428B2C-06E9-447C-9184-AB91D83DFAB5Q30405464-502775BF-D7C0-4E13-80FC-78BCD239DB40Q30429961-D55BF418-6AC5-482D-8EDC-B07062872488Q30494794-9E482B43-3938-4CE7-AF22-BA69BF91277CQ33555117-280F195A-58B8-46C2-BCC6-E5ED2D691C2AQ33731849-736D56AA-A2EC-46C7-8919-863EDAA5E896Q33813295-E92F052E-C066-4301-A4AA-BADE679D72F4Q33816405-E5D7A360-AFD7-45F1-9D3B-9D4F75FF1126Q33915290-2BCB075C-917B-45D8-9168-A19D96354868Q33922867-0D66B16B-DA45-4786-B947-DA0481A43F9AQ34003041-E5D29E47-2AEB-46DF-A92B-027656540C64Q34032522-43A806C5-4136-4860-9014-30EBE6B53466Q34204432-2B743767-00DE-4F7F-A3B8-544A3272D21EQ34266725-00A8394C-524F-423D-B87D-0E6AD3155D8DQ34294641-B055BDCE-7501-427F-96AB-5FAB6DF7F121Q34303315-BEAF6FB1-6345-4585-8FE4-1C16DA69601DQ34397465-67CC7C88-5AE6-42DE-80E0-809A0B95BB2BQ34556081-235F7D71-2B8A-4770-B9ED-E8D0C86D16C8Q34589244-01F9E174-52E4-4055-A6F6-888A67AC79F3Q34629278-CC68522E-7306-47A8-A1AC-96E9A00AABD4Q34655780-7EF0FD6B-30E3-4C0D-8FFE-5B7D6D9BAE7AQ34797596-31C72699-9775-4FD4-A400-F30B13618C69Q34808054-11F22965-AFFD-487C-9B30-3BDDCF64F3B8Q34837055-58CAEB52-1430-4887-81B4-8A741CA33D2CQ34838614-795EBD86-582B-49EB-847B-6444BF896D86Q35065037-880D15F2-407B-4C97-8840-DBEBBECB356EQ35085864-C9FA08C6-3AE2-434E-8714-42E25555E9C9Q35097182-47E0BD8D-CC4B-4DC9-AAF0-21352CBC1307
P2860
A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A homozygous frameshift mutati ...... percutaneous allergen priming.
@ast
A homozygous frameshift mutati ...... percutaneous allergen priming.
@en
type
label
A homozygous frameshift mutati ...... percutaneous allergen priming.
@ast
A homozygous frameshift mutati ...... percutaneous allergen priming.
@en
prefLabel
A homozygous frameshift mutati ...... percutaneous allergen priming.
@ast
A homozygous frameshift mutati ...... percutaneous allergen priming.
@en
P2093
P2860
P50
P356
P1433
P1476
A homozygous frameshift mutati ...... percutaneous allergen priming
@en
P2093
Aiko Shiohama
Aileen Sandilands
Hiroshi Kawasaki
John P Sundberg
Linda E Campbell
Nobuyoshi Shimizu
Philip Fleckman
Takashi Sasaki
P2860
P2888
P304
P356
10.1038/NG.358
P407
P50
P577
2009-04-06T00:00:00Z